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TO THE EDITORIs Coronary Wedge
Pressure a Technique to
Identify High-Risk Patients
Who May Beneﬁt From
Alternative Treatment in
Acute Myocardial Infarction?Is This The Next Step?We read with interest the paper by Patel et al. (1)
about the OxAMI (Oxford Acute Myocardial Infarc-
tion) study. The paper shows how zero-ﬂow pressure
(Pzf) measured immediately after the primary percu-
taneous coronary intervention for ST-segment
elevation predicts the extent of the myocardial
infarction at 6 months.
The study shows an interesting result: Pzf was
signiﬁcantly lower in the group with normal surrogate
parameters of microvascular obstruction (MO) and
smaller infarct size. The invasive coronary measure-
ments were performed after revascularization, and in
this case Pzf reﬂects the MO, which is the result of
embolization that occurred before the procedure and
after thrombus aspiration and stenting. It would be
interesting to know the differences in size and
composition of the thrombus between the 2 groups.
High thrombus burden and old age thrombus are
associated with pre-procedural MO. Older thrombus
requires a longer period of nonocclusive formation on
the unstable coronary plaque or erosion. During this
phase, the platelet-rich thrombus is unstable and is
prone to embolize into the distal microcirculation
even before primary percutaneous coronary inter-
vention (2).
The determination of Pzf after revascularization is
probably time-consuming, and it is based on an
extrapolation from the pressure-velocity loops.
Furthermore, this study highlights only a prognostic
issue and not an immediate therapeutic one.
However, determination of the coronary wedge
pressure (CWP) before revascularization is a
very simple method of microvascular functionassessment. In acute myocardial infarction, the
vessel is usually totally occluded and the CWP
determination is easy to do. In such cases, the
mean pressure distal to the occlusion is nothing
other than the CWP and depends on the collateral
ﬂow, which “unfortunately” is modest, especially
if no collaterals are seen on angiography. Pzf is the
distal coronary pressure when, theoretically, the
ﬂow in a coronary artery is zero and no functional
collaterals exist.
So, in this setting of MO, because the pressure-
ﬂow relation without collateral ﬂow is linear at
physiological pressures (3), Pzf and CWP are similar
parameters, although they are different in way of
determination. It has been proven that higher
CWPs are caused by extensive microvascular dys-
function and impeded drainage of the pre-capillary
compartment (4). CWP could be determined by using
a thin infusion catheter, and if the pressure is high,
reﬂecting a pre-procedural MO, downstream admin-
istration of some drugs like glycoprotein IIb/IIIa
inhibitors or thrombolytics could be beneﬁcial (5).
In our experience, we have found the a CWP
value of 30 mm Hg as a cutoff for MO in acute
anterior myocardial infarction and no collateralized
left anterior descending artery occlusion, and this
was similar to other studies (4). Downstream epti-
ﬁbatide administration in the group of patients with
CWP higher than this cutoff was effective regarding
the post-procedural surrogate parameters of MO.
In the downstream drug administration, issues
of both distal embolization and lack of contact
between the distal platelet-rich embolized thrombus
and the glycoprotein IIb/IIIa inhibitors or thrombo-
lytics are addressed. By doing so, the CWP evalua-
tion opens a new therapeutic approach in this yet
unresolved issue of MO, thus getting closer to the
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REPLY: Is Coronary WedgePressure a Technique to Identify High-Risk
Patients Who May Beneﬁt From Alternative
Treatment in Acute Myocardial Infarction?
Is This The Next Step?We would like to thank Prof. Iancu and colleagues
for their comments about our recent publication (1).
They raise 3 important points:
1. Which patient and procedural factors impact on
microvascular function (MF) after primary angio-
plasty (PPCI)? We have not analyzed thrombus size
and composition, but we agree that this could
provide insights into the mechanisms of MF
observed at the completion of PPCI. MF is multi-
factorial in this situation, reﬂecting a combination
of ischemic injury, prior and procedure-associated
distal embolization, and patient factors such as
age and diabetes. We have recently addressed the
speciﬁc effect of coronary stent implantation on
MF, and identiﬁed that the most important
determinants of change in MF are lesion location,
thrombus burden, implanted stent volume, and
baseline MF (2).
2. Use of coronary wedge pressure (CWP): There are a
number of indices of MF available. The speciﬁc aim
of our study was to compare Doppler and
thermodilution-derived indices. We agree that
ofﬂine analysis is time-consuming, but we do not
believe that this ﬁnding provides only prognosticinformation. We have previously shown that ﬁnal
myocardial salvage is related to both end-of-
procedure MF and how MF changes over the sub-
sequent day, suggesting that identiﬁcation of
patients with impaired MF at the completion of
PPCI could identify an especially high-risk group in
which additional interventions maybe most bene-
ﬁcial (3).
3. Assessment of CWP before coronary stenting: CWP
provides a simple measure, but in patients with
collateral ﬂow especially, it is maybe less reliable
than a number of alternative indices. Ultimately,
however, an enhanced understanding of the coro-
nary microcirculation at the time of PPCI and the
utility of different measures is essential if we are to
achieve better outcomes from reperfusion for all of
our patients.Niket Patel, MBBS, BSc
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Personalized Antiplatelet
TherapyThe Odyssey ContinuesWe read with great interest the RECLOSE 3
(REsponsiveness to CLOpidogrel and Stent Throm-
bosis 3) study reported by Valenti et al. (1) in which
